Advertisement

Index by author

November 01, 1994; Volume 22,Issue 6

  1. Alton, K B

    1. Urinary metabolites of (R),(R)-labetalol.
      K B Alton, T M Chan and B N Pramanik
      Drug Metabolism and Disposition November 1994, 22 (6) 866-872;

  2. Anders, M W

    1. Tissue distribution and stereoselectivity of remacemide-glycine hydrolase.
      H Heyn, Y G Bankmann and M W Anders
      Drug Metabolism and Disposition November 1994, 22 (6) 973-974;

  3. Ardouin, T

    1. Pharmcokinetics in healthy volunteers and patients of NAc-SDKP (seraspenide), a negative regulator of hematopoiesis.
      E Ezan, P Carde, J Le Kerneau, T Ardouin, F Thomas, F Isnard, E Deschamps de Paillette and J M Grognet
      Drug Metabolism and Disposition November 1994, 22 (6) 843-848;

  4. Babu, S R

    1. Glucuronidation of N-acetylbenzidine by human liver.
      S R Babu, V M Lakshmi, T V Zenser and B B Davis
      Drug Metabolism and Disposition November 1994, 22 (6) 922-927;

  5. Bankmann, Y G

    1. Tissue distribution and stereoselectivity of remacemide-glycine hydrolase.
      H Heyn, Y G Bankmann and M W Anders
      Drug Metabolism and Disposition November 1994, 22 (6) 973-974;

  6. Barnett, J L

    1. Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.
      K S Lown, J C Kolars, K E Thummel, J L Barnett, K L Kunze, S A Wrighton and P B Watkins
      Drug Metabolism and Disposition November 1994, 22 (6) 947-955;

  7. Boelsterli, U A

    1. Mechanism of covalent adduct formation of diclofenac to rat hepatic microsomal proteins. Retention of the glucuronic acid moiety in the adduct.
      A Kretz-Rommel and U A Boelsterli
      Drug Metabolism and Disposition November 1994, 22 (6) 956-961;

  8. Bonner, H S

    1. Metabolic pathways of WR-2721 (ethyol, amifostine) in the BALB/c mouse.
      L M Shaw, H S Bonner and D Q Brown
      Drug Metabolism and Disposition November 1994, 22 (6) 895-902;

  9. Boyd, S A

    1. The orally active renin inhibitor A-74273. In vivo and in vitro morpholine ring metabolism in rats, dogs, and humans.
      J F Denissen, B A Grabowski, M K Johnson, S A Boyd, J T Uchic, H Stein, S Cepa and P Hill
      Drug Metabolism and Disposition November 1994, 22 (6) 880-888;

  10. Brennan, J M

    1. Stereoselective pharmacokinetics of L-buthionine SR-sulfoximine in patients with cancer.
      F P Lacreta, J M Brennan, T C Hamilton, R F Ozols and P J O'Dwyer
      Drug Metabolism and Disposition November 1994, 22 (6) 835-842;
« Previous (Pages : 1 2 3 4 5 6 ... 11) Next »
Back to top

In this issue

Advertisement